---
title: "Navigating Health Care in Malta: A Perspective on Free Medical Services and Challenges"
id: "stat-news-0-opinion-i-moved-to-europe-for-free-health-care-i-miss-my-patient-portal"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-opinion-i-moved-to-europe-for-free-health-care-i-miss-my-patient-portal"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/11/04/moving-to-europe-free-health-care-differences/?utm_campaign=rss"
published_at: "2026-11-04T09:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Navigating Health Care in Malta: A Perspective on Free Medical Services and Challenges
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-opinion-i-moved-to-europe-for-free-health-care-i-miss-my-patient-portal
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/11/04/moving-to-europe-free-health-care-differences/?utm_campaign=rss)
- **Published At:** 2026-11-04T09:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Author Mariska Breland shares her experiences transitioning from U.S. health care to Malta's system. - U.S. health care unaffordability prompted her move, paying €38 per week in Malta for comprehensive coverage. - The article describes differences in medical assistance logistics, including reliance on paperwork and delays in the public sector. - Concerns persist about available treatments and medical resources in Malta, especially for specific conditions like multiple sclerosis. - Despite the transition, Breland longs for the ease of the digital patient portal from her previous U.S. providers.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/11/04/moving-to-europe-free-health-care-differences/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/04/moving-to-europe-free-health-care-differences/?utm_campaign=rss) [Medicaid](https://www.statnews.com/topic/medicaid/) [ethics](https://www.statnews.com/topic/ethics/) [Congress](https://www.statnews.com/topic/congress/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) Opinion[First Opinion](https://www.statnews.com/category/first-opinion/) # I moved to Europe for free health care. I miss my patient portal ## An American navigates health care in Malta * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/11/04/moving-to-europe-free-health-care-differences/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/11/GettyImages-2274347685-645x645.jpg) Residential buildings stand on a hillside above a road and greenery in Mellieħa, Malta.Martin Bertrand / Hans Lucas / AFP via Getty Images By Mariska Breland Nov. 4, 2026 Breland is a co-founder of The Neuro Studio. Tuesday, at exactly 7 a.m., I arrived at my general practitioner’s office, in the basement level of his house, two blocks from mine in Mellieħa, Malta. There are six chairs in the waiting area. Ikea, I think. People note who got there first and go in, in turn. On his desk, there’s an ancient laptop with a big monitor running a vaguely Y2K version of Windows. He wears a digital Casio watch I remember my dad having in the 1980s. My American doctor’s office had a water feature. My Malta doctor does bloodwork by appointment only, Tuesdays at 7 a.m. You tell him in advance what you need, and he has the tubes ready, hand-labeled with your resident number. The tubes are tracking the two diseases I brought with me. The number is what gets you into a socialized system that spends [a quarter](https://www.oecd.org/en/publications/health-at-a-glance-2025_15a55280-en/united-states_3517f35e-en.html) of what America costs per person and still has an average life expectancy of five more years. It’s not the Mediterranean diet doing the work. Malta has the [highest obesity rates](https://eurohealthobservatory.who.int/docs/librariesprovider3/country-health-profiles/chp2023pdf/chp-malta.pdf) in adults in all of the E.U. Advertisement While I sat there, gauze pressed on the vein that just held the needle, he filled out a form for the lab, correcting an error with white-out tape. You can buy that down the street at the store that sells water shoes and postcards. I miss my portal. * * * I left the United States for a variety of reasons, including that you can swim in the Potomac but shouldn’t. You can bask in the Mediterranean and should. But mostly, it was a calculation about health care. American medicine saved me, literally, more than once. My care was extraordinary, and it was also about to become extraordinarily unaffordable. I pay 38 euros a week here — about $2,300 a year — and it covers me and my medications, including the one that costs $80,000 per year in the U.S. Advertisement Related Story ![](https://www.statnews.com/wp-content/uploads/2024/12/DSC02136-768x432.jpg) ### [Spending less, living longer: What the U.S. can learn from Portugal’s innovative health system](https://www.statnews.com/2024/12/10/us-health-care-system-reform-how-portugal-spend-less-increased-life-expectancy/) My medical resume is diverse. I’ve had multiple sclerosis since 2002. I had breast cancer. I have half a liver. I once broke my leg in three places — while standing still. In my adult life I have hit the catastrophic out-of-pocket maximum nearly every year. Like most insured Americans, I had coverage through my employer, and later through my husband Brian’s employer, the federal government. My doctors were department heads at Georgetown and Johns Hopkins. The surgeon who repaired my leg did his residency at the Hospital for Special Surgery, the top-ranked orthopedic hospital in the country. I got him because he was on call. My post-mastectomy plastic surgeon had once chaired the board that certifies plastic surgeons. All of them. For the whole country. Every visit was a $40 copay. Self-referral. My maximum out-of-pocket was $6,000. The plan cost $26,888 a year — Brian paid $9,988 and his employer paid the rest. We never thought about it. * * * Then came DOGE, which was clearing out the federal workforce in the name of preventing waste, fraud, and abuse. Brian worked for an Inspector General’s office that investigated and prosecuted … waste, fraud, and abuse. He never got fired. But we didn’t want to live in the risk. He wanted to move into consulting, which meant buying insurance on the exchange. I am an insurance company’s nightmare. Federal law currently says they have to take me. To be extra safe, we planned to go to New York, where Brian’s family lives, because preexisting conditions are written into state law. The cheapest mid-level plan, including copays and deductibles, ran about $30,000 for the year for both of us. That was the 2026 number. Open enrollment for 2027 coverage runs Nov. 1 to Dec. 15. That’s a shorter timeframe than previous years, and marketplace premiums are up [an average of 26%](https://www.ajmc.com/view/newly-unveiled-aca-premiums-show-26-average-increase-before-subsidy-expiration) for 2026. United Healthcare is [requesting](https://www.cbsnews.com/newyork/news/health-insurance-premiums-increase-2027-new-york/) a 52% increase for New York for 2027. Millions of Americans are running the numbers now. Two incomes down to one. Our health care costs tripling from what we paid with Brian’s job. After a lot of thought and a single Excel spreadsheet, we decided our best option wasn’t New York after all. My mother, long dead, ended up being the deciding factor. Advertisement My mother left me an E.U. passport. That is not a financial plan or a policy proposal or anything I earned — it is an inheritance like my green eyes and forehead veins, and it is the only reason any of what follows was available to me. Most Americans with a condition like mine don’t have an escape hatch to the European Union. I did. And I had been claiming socialized medicine was ideal — the way! — for decades without ever having participated in it. * * * My social security contribution — that 38 euros a week — gives the entitlement. Hospital stay in Malta? Free. Emergency helicopter rescue? Free. There is no prior authorization. No requirement to fail a cheaper drug before getting a better one. Nobody has sent me the letter I used to get every year from my U.S. insurer, announcing they would not cover my medication because they believed I had a secondary insurance policy I have never had. Every. Single. Year. At least twice a year, my doctor would be on the phone yelling at an insurance company for denying coverage. There are people whose entire job it is to file those appeals. According to a [2025 AMA survey](https://www.ama-assn.org/press-center/ama-press-releases/ama-survey-prior-authorization-reform-pledge-falls-short-physicians), U.S. doctors average 40 prior authorizations per week, and their practices spend 13 hours a week on them. Forty percent of doctors employ staffers just to deal with insurance companies. And about three-quarters of physicians report that denials have increased over the past five years. * * * To be honest, in Malta, I pay for medical care all the time. I just pay differently. Related Story ![](https://www.statnews.com/wp-content/uploads/2024/03/methadone_2295-768x432.jpg) ### [Switzerland had a drug overdose crisis. Then it made methadone easy to get](https://www.statnews.com/2024/03/26/opioid-addiction-methadone-treatment-switzerland-europe/) There’s a two-tiered medical system. Public and private. The care is guaranteed. Speed and convenience live wholly in the private tier. I can walk into almost any pharmacy in Malta and see a GP operating privately that same day for 15 to 20 euros. A specialist is 70 euros. Always cash. Sometimes you get a receipt. An ultrasound — if you want it fast — is 120 euros. Mine was performed by a doctor specializing in breast cancer imaging. No tech. No radiologist to read it later. I got the report at the appointment. Advertisement Most specialists here see patients both publicly and privately, and many private appointments happen inside pharmacies. There are tiny offices tucked in the back or upstairs. My neurologist works in a hospital one day a week. The other four days he works in four different pharmacies. You pick the one closest to where you live or work or shop. When I asked him why the system works that way, he said, literally, “to make it convenient for the patients.” There is no lease, no waiting room, no receptionist, and no billing department because there is nothing to bill. You pay at the counter where the eye drops are. In Attard, where I see him because it’s closest to my house, he works Tuesday mornings alongside a gynecologist, a nephrologist, and an ophthalmologist. The next day will be a different group. Malta has more than 200 licensed community pharmacies, dispensing medical care alongside prescriptions, sunscreen, nail polish remover, a surprisingly robust collection of perfumes, and subpar dental floss. I ship that in from the U.K. When I needed an oncology checkup, I found Dr. Brincat, who ran the oncology department at Mater Dei Hospital for 17 years. I called a private clinic where he works now. They checked his schedule, called me back the next day, and gave me an appointment just two weeks out. He scanned (visually, not electronically) more than 100 pages of my records. Other than the paper on his desk, there was a stethoscope. No computer. No iPad. No phone. He ordered a hormone panel to see whether I should switch from tamoxifen to an aromatase inhibitor — something my American oncologist had said we’d get to at some point. They were in agreement on the protocol. He ordered an ultrasound, handwriting a referral on letterhead and sealing it in an envelope from his top desk drawer. It feels like time traveling back to the ’80s. But I’ve never had a doctor who needed to prove I needed anything. And a bill? Never seen one. * * * The private tier is easy. The public tier is where my medical fluency in the U.S. didn’t translate. I have to plan for things I never considered before. Like the speed of mail. Advertisement Before Dr. Brincat, I tried to do it the correct way, or rather, the free one. My GP requested a referral, and I was told to watch the mail for an appointment slip. The time you are given is not negotiable. The time is the time. The slip should arrive in roughly two weeks following the request. I waited. When I called, they said they were still looking for a time for me. The horror story Americans tell about socialized medicine is the wait. If you need a hip — good luck, check back in three years. A friend of mine recently went from hip pain to a bad X-ray to a new hip in under 10 weeks in America. She also has excellent insurance, which is the entire sentence. America is the fastest system for some of its people. For the uninsured, the wait is not a year or three. It is indefinite. Related Story ![](https://www.statnews.com/wp-content/uploads/2026/06/AdobeStock_281524922-768x432.jpeg) ### [How living and practicing medicine abroad complicated my beliefs about universal health care systems](https://www.statnews.com/2026/06/05/universal-health-care-system-tradeoffs-accountability/) I wasn’t prepared for the Maltese system paperwork, emphasis on the paper. To get my medication free, the Pharmacy of Your Choice program required proof that I had paid into social security — because there is no centralized system that simply shows that … I have. Buy a printer/scanner. You will need it. I scanned and sent my receipts. They replied: _Thank you for contacting the POYC Schedule V office. This is to acknowledge receipt of your email. We will reply to your email in due course._ I have four similar messages in a folder named “Bureaucracy Stuff.” After three weeks of due course, I called. My form had been mailed, they said, and must have been lost. They would mail it again. I could expect it in 10 business days. I asked whether I could just come get it. They said yes, they were open until 1 p.m. It took me 32 minutes, door to door, in heavy traffic. In America, there is paperwork to prove you deserve a drug or surgery or treatment because the insurance company doesn’t want to give it to you. In Malta, there’s paperwork because there are forms and they are still on paper. I have not received reminder texts here. No confirmation calls. I think I have a dermatologist appointment next week. Am I sure? No. I will show up and hope. Advertisement * * * I worry that if my cancer comes back, I won’t have what I would have had in the U.S. The doctors are good here. But the bench isn’t as deep. There are more MS drugs available in America than here — but not the one developed for my subtype. Tolebrutinib, sold as Cenrifki, is the drug American patients lobbied hard for. The Food and Drug Administration rejected it over risk of severe liver injury and questions of efficacy. The European regulator [approved it in June](https://www.neurologylive.com/view/where-tolebrutinib-fits-weighing-eu-approval-fda-divergence-and-road-ahead-nrspms). It’s the first drug shown to reduce disability in non-relapsing secondary progressive MS, and I’m in that group, and there is nothing else. But it won’t come to Malta soon. Just because E.U. approved it doesn’t mean it gets to Malta because there aren’t enough patients to warrant it. There are more people with MS in the United States — nearly a million — than there are people in my entire country. * * * I did learn recently that there is a portal for the public system. For the private system, I keep a folder on my phone of photographs of my
## Related Clinical Research

- [Vitamin B5 derivative linked to reduced psoriasis plaques and inflammation in small trial](https://medichelpline.com/clinical-feed/medical-news-today-0-vitamin-b5-derivative-may-reduce-psoriasis-plaques-and-inflammation-small-trial.md)
- [Retatrutide: A New Approach for Easing Knee Osteoarthritis Pain](https://medichelpline.com/clinical-feed/medical-news-today-0-new-weight-loss-drug-eases-knee-osteoarthritis-pain-in-major-trials.md)
- [NIH to relocate its last research chimpanzees to Chimp Haven sanctuary](https://medichelpline.com/clinical-feed/stat-news-1-stat-nih-to-move-last-group-of-its-research-chimps-to-a-sanctuary.md)
- [FDA after Overton: 7 questions about the agency’s next leadership and priorities](https://medichelpline.com/clinical-feed/stat-news-2-stat-7-burning-questions-about-the-fda-s-post-overton-future.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.